Enlivex Therapeutics Ltd. (NASDAQ:ENLV) currently has 21 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 313,628 | 156,336 | 99.39% | $220,543.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 200,627 | 27,002 | 15.55% | $141,081.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 195,126 | 184,387 | 1,716.98% | $137,213.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 153,990 | 135,198 | 719.44% | $108.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 85,098 | 84,973 | 67,978.40% | $59,824.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 74,082 | 52,553 | 244.10% | $52,095.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 61,800 | 61,800 | 0.00% | $43,458.00 |
| UBS Group AG | 31 Dec, 2025 | 34,988 | 30,948 | 766.04% | $24,596.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 25,587 | -43,349 | -62.88% | $17,993.00 |
| Prosperity Consulting Group, LLC | 31 Dec, 2025 | 17,647 | 0 | 0.00% | $12,409.00 |
| Neuberger Berman Group LLC | 31 Dec, 2025 | 10,988 | 0 | 0.00% | $7,727.00 |
| WELLS FARGO & COMPANY/MN | 31 Dec, 2025 | 9,184 | 0 | 0.00% | $6,458.00 |
| SIMPLEX TRADING, LLC | 31 Dec, 2025 | 8,878 | 8,878 | 0.00% | $6,243.00 |
| Tower Research Capital LLC (TRC) | 31 Dec, 2025 | 2,238 | 2,238 | 0.00% | $1,573.00 |
| OSAIC HOLDINGS, INC. | 31 Dec, 2025 | 2,140 | 10 | 0.47% | $1,503.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 2,122 | 2,022 | 2,022.00% | $1,492.00 |
| Arax Advisory Partners | 31 Dec, 2025 | 1,015 | 0 | 0.00% | $714.00 |
| Activest Wealth Management | 31 Dec, 2025 | 1,000 | 0 | 0.00% | $703.00 |
| BFSG, LLC | 31 Dec, 2025 | 1,000 | 0 | 0.00% | $704.00 |
| Steward Partners Investment Advisory, LLC | 31 Dec, 2025 | 500 | -2,000 | -80.00% | $352.00 |